Oncology How precision medicine treats an overlooked clinical variabl... In oncology, time is not simply a measure of care; it is a clinical variable – and increasingly a therapeutic challenge.
Patients Is women’s health reaching an inflection point? A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.
Oncology ASCO 2026 reshapes oncology trial design The American Society of Clinical Oncology 2026 annual meeting showcased how, across tumour types, new cancer therapies are achieving deeper responses, extending survival and increasingly mo
R&D Beyond proof of concept: Alzheimer’s and the next chapter of... Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.
R&D Parkinson’s disease: Transitioning from symptom control to d... The Parkinson's disease field is increasingly moving toward biologically defined disease frameworks using molecular biomarkers.
News Parkinson's charity partners Biognosys on biomarker project A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.